Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikkel Fode

Showing results (41-50 of 194) with videos related to

Pageof 20
Sort By:
The Journal of Sexual Medicine|July 5, 2014
Prevalence and predicting factors for commonly neglected sexual side effects to radical prostatectomies: results from a cross-sectional questionnaire-based studyAnders Frey, Jens Sønksen, Henrik Jakobsen, et al.
European Urology|September 5, 2018
Intralesional and Mechanical Therapies for Peyronie's Disease: A Road Anything but StraightPaolo Verze, Marco Capece, Massimiliano Creta, et al.
Scandinavian Journal of Urology|July 10, 2013
Satisfaction and complications with the Titan® one-touch release penile implantLisa Lindeborg, Mikkel Fode, Lasse Fahrenkrug, et al.
Scandinavian Journal of Urology|November 6, 2015
Erectile function after radical prostatectomy: Do patients return to baseline?Mikkel Fode, Anders Frey, Henrik Jakobsen, et al.
European Urology Focus|February 20, 2019
Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?Premal Patel, Mikkel Fode, Tom Lue, et al.
Ugeskrift for Laeger|January 3, 2017
[Problems in the gastrointestinal and urinary tract system and sexual dysfunction in patients suffering from multiple sclerosis]Laura Victoria Falck Giraldi, Jens Sønksen, Mikkel Fode
Scandinavian Journal of Urology|December 31, 2022
Feasibility of minimally invasive, same-day injection of autologous adipose-derived stem cells in the treatment of erectile dysfunctionMikkel Fode, Naomi Nadler, Lars Lund, et al.
European Urology Focus|July 21, 2017
Sexually Transmitted Disease and Male Infertility: A Systematic ReviewMikkel Fode, Ferdinando Fusco, Larry Lipshultz, et al.
European Urology Focus|May 5, 2026
Reply to Singh and Srivastav's Letter to the Editor re: Amy Lockefeer, Arianne Schild, Swapneel Anaokar, et al. Efficacy and Safety of Mirabegron in Patients with Overactive Bladder and Cardiovascular Comorbidities: A Post Hoc Analysis of Randomised Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.01.010Amy Lockefeer, Arianne Schild, Swapneel Anaokar, et al.
International Journal of Impotence Research|March 23, 2024
Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study"Emil Durukan, Christian Fuglesang Skjødt Jensen, Mikkel Fode
Pageof 20

Showing results (41-50 of 194) with videos related to

Sort By:
Pageof 20
The Journal of Sexual Medicine|July 5, 2014
Prevalence and predicting factors for commonly neglected sexual side effects to radical prostatectomies: results from a cross-sectional questionnaire-based studyAnders Frey, Jens Sønksen, Henrik Jakobsen, et al.
European Urology|September 5, 2018
Intralesional and Mechanical Therapies for Peyronie's Disease: A Road Anything but StraightPaolo Verze, Marco Capece, Massimiliano Creta, et al.
Scandinavian Journal of Urology|July 10, 2013
Satisfaction and complications with the Titan® one-touch release penile implantLisa Lindeborg, Mikkel Fode, Lasse Fahrenkrug, et al.
Scandinavian Journal of Urology|November 6, 2015
Erectile function after radical prostatectomy: Do patients return to baseline?Mikkel Fode, Anders Frey, Henrik Jakobsen, et al.
European Urology Focus|February 20, 2019
Should Low-intensity Extracorporeal Shockwave Therapy Be the First-line Erectile Dysfunction Treatment for Nonresponders to Phosphodiesterase Type 5 Inhibition?Premal Patel, Mikkel Fode, Tom Lue, et al.
Ugeskrift for Laeger|January 3, 2017
[Problems in the gastrointestinal and urinary tract system and sexual dysfunction in patients suffering from multiple sclerosis]Laura Victoria Falck Giraldi, Jens Sønksen, Mikkel Fode
Scandinavian Journal of Urology|December 31, 2022
Feasibility of minimally invasive, same-day injection of autologous adipose-derived stem cells in the treatment of erectile dysfunctionMikkel Fode, Naomi Nadler, Lars Lund, et al.
European Urology Focus|July 21, 2017
Sexually Transmitted Disease and Male Infertility: A Systematic ReviewMikkel Fode, Ferdinando Fusco, Larry Lipshultz, et al.
European Urology Focus|May 5, 2026
Reply to Singh and Srivastav's Letter to the Editor re: Amy Lockefeer, Arianne Schild, Swapneel Anaokar, et al. Efficacy and Safety of Mirabegron in Patients with Overactive Bladder and Cardiovascular Comorbidities: A Post Hoc Analysis of Randomised Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.01.010Amy Lockefeer, Arianne Schild, Swapneel Anaokar, et al.
International Journal of Impotence Research|March 23, 2024
Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study"Emil Durukan, Christian Fuglesang Skjødt Jensen, Mikkel Fode
Pageof 20